Format

Send to

Choose Destination
J Am Acad Dermatol. 2011 Feb;64(2):217-28; quiz 229-30. doi: 10.1016/j.jaad.2010.05.045.

Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.

Author information

1
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Nicole.Fett@uphs.upenn.edu

Abstract

Morphea, also known as localized scleroderma, is a rare fibrosing disorder of the skin and underlying tissues. Morphea is differentiated from systemic sclerosis based on the absence of sclerodactyly, Raynaud phenomenon, and nailfold capillary changes. Patients with morphea commonly have systemic symptoms, such as malaise, fatigue, arthralgias, and myalgias, as well as positive autoantibody serologies. However, involvement of morphea is almost uniformly limited to those tissues derived from the mesoderm. The underlying pathogenesis of morphea is incompletely understood at this time, but ultimately results in an imbalance of collagen production and destruction.

PMID:
21238823
DOI:
10.1016/j.jaad.2010.05.045
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center